Aptus Pharma share news, announcements and annual reports
BSE: 544529Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 27 Oct 2026. Previous close ₹481.70.
27 Oct: open ₹472.10, high ₹472.10, low ₹472.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹810 Cr2,265th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 101.85
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 28.49
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 31.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.43
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 11,600
Aptus Pharma has 62 announcements on record, routine notices left out; 5 in the 30 days to 28 Oct 2026, the latest on 26 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Aptus Pharma half-yearly results
The board met on 20 Oct 2026 to consider half yearly results
Notice filed 16 Oct 2026
Aptus Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Aptus Pharma financials, year by year
Annual reports1
- Annual report, year to Mar 202621 Aug 2026
Investor presentations4
- Intimation of Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201523 Oct 2026
- Intimation of investor presentation under regulation 30 of SEBI (LODR) Regulations, 201521 Aug 2026
- Announcement Under Regulation 30 (LODR): Investor Presentation29 May 2026
- Intimation of Investor Presentation under Regulation 30 of SEBI (LODR) Regulations, 20157 Feb 2026
Earnings calls1
Aptus Pharma share news and announcements
Newest first. Page 1 of 2.
Oct 2026
16 Oct · Board meeting
Meeting on 20 Oct 2026: half yearly results
Sep 2026
17 Sep · Analysts
14 Sep · Meeting
12 Sep · Analysts
Aug 2026
17 Aug · Board meeting
12 Aug · Board meeting
Meeting on 17 Aug 2026: annual general meeting5 Aug · Board meeting
Meeting on 8 Aug 2026: preferential issue of shares
Jun 2026
12 Jun · Board meeting
9 Jun · Board meeting
Meeting on 12 Jun 2026: preferential issue of shares
May 2026
22 May · Brand Promotion Initiative At Rajkot Hirasar Airport
15 May · Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations, 2015
Apr 2026
27 Apr · Corporate action
27 Apr · Results
25 Apr · Disclosure Regarding Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
20 Apr · Board meeting
Meeting on 27 Apr 2026: audited results
Mar 2026
26 Mar · Meeting
24 Mar · Board meeting
17 Mar · Board meeting
Meeting on 24 Mar 2026: bonus issue and increase in authorised capital
Feb 2026
Dec 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 29 Jun 2026Credit ratingdown 1.76%−1.3 pts vs Nifty 500market median 0.0% · five sessions −0.5% (−1.3 pts vs Nifty 500) · volume 0.8× usual · The announcement